Last updated: April 15, 2024
Sponsor: Simon Fraser University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Orthostatic Hypotension
Cataplexy
Dizzy/fainting Spells
Treatment
blood-injection-injury (BII) phobia stimuli
neutral stimuli
Clinical Study ID
NCT06336031
30002163
Ages 18-50 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- male and female
- 18 to 50 years old
- those without a suspected BII fear and those with a suspected fear
- english speaking
Exclusion
Exclusion Criteria:
- diagnosis of any cardiovacular or neurological disorder
- menopausal
- taking medication for a cardiovascular condition
- if they are pregnant
Study Design
Total Participants: 20
Treatment Group(s): 2
Primary Treatment: blood-injection-injury (BII) phobia stimuli
Phase:
Study Start date:
March 30, 2024
Estimated Completion Date:
February 28, 2025
Study Description
Connect with a study center
Simon Fraser University
Burnaby, British Columbia V5A 1S6
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.